EBM analysis
Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health
Antoine Vanier, Judith Fernandez, Sophie Kelley, Lise Alter, Patrick Semenzato, Corinne Alberti, Sylvie Chevret, Dominique Costagliola, Michel Cucherat, Bruno Falissard, François Gueyffier, Jérôme Lambert, Etienne Lengliné, Clara Locher, Florian Naudet, Raphael Porcher, Rodolphe Thiébaut, Muriel Vray, Sarah Zohar, Pierre Cochat, Dominique Le Guludec
doi: 10.1136/bmjebm-2022-112091
